Effects of Poloxamer 188 on red blood cell membrane properties in sickle cell anaemia

Vaso‐occlusive crisis (VOC) is the main acute complication in sickle cell anaemia (SS) and several clinical trials are investigating different drugs to improve the clinical severity of SS patients. A phase III study is currently exploring the profit of Velopoloxamer in SS during VOCs. We analysed, in‐vitro, the effect of poloxamer (P188) on red blood cell (RBC) properties by investigating haemorheology, mechanical and adhesion functions using ektacytometry, microfluidics and dynamic adhesion approaches, respectively. We show that poloxamer significantly reduces blood viscosity, RBC aggregation and adhesion to endothelial cells, supporting the beneficial use of this molecule in SS therapy.

[1]  Mark R Morgan,et al.  Emerging properties of adhesion complexes: what are they and what do they do? , 2015, Trends in cell biology.

[2]  B. Le Pioufle,et al.  A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen , 2015, American journal of hematology.

[3]  A. Pichon,et al.  Indirect viscosimetric method is less accurate than ektacytometry for the measurement of red blood cell deformability. , 2015, Clinical hemorheology and microcirculation.

[4]  O. Hue,et al.  Haemolysis and abnormal haemorheology in sickle cell anaemia , 2014, British journal of haematology.

[5]  J. Elion,et al.  Hydroxycarbamide Decreases Sickle Reticulocyte Adhesion to Resting Endothelium by Inhibiting Endothelial Lutheran/Basal Cell Adhesion Molecule (Lu/BCAM) through Phosphodiesterase 4A Activation* , 2014, The Journal of Biological Chemistry.

[6]  J. Barthélémy,et al.  Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation , 2011, Haematologica.

[7]  R. Hunter,et al.  Poloxamer 188 inhibition of ischemia/reperfusion injury: evidence for a novel anti-adhesive mechanism. , 2010, Annals of clinical and laboratory science.

[8]  Mario Jolicoeur,et al.  The fate of Pluronic F‐68 in chondrocytes and CHO cells , 2008, Biotechnology and bioengineering.

[9]  K. Ataga,et al.  Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. , 2001, JAMA.

[10]  H. Meiselman,et al.  Modulation of red blood cell aggregation and blood viscosity by the covalent attachment of Pluronic copolymers. , 2001, Biorheology.

[11]  H. Meiselman,et al.  Inhibition of polymer-induced red blood cell aggregation by poloxamer 188. , 2000, Biorheology.

[12]  L Tung,et al.  Poloxamer 188 decreases susceptibility of artificial lipid membranes to electroporation. , 1996, Biophysical journal.

[13]  R. Nagel,et al.  The pathophysiology of vascular obstruction in the sickle syndromes. , 1996, Blood reviews.

[14]  J. White,et al.  Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. , 1980, The Journal of clinical investigation.

[15]  J. Wear,et al.  Effect of fluorocarbon emulsions on the mechanical fragility of normal and sickle cells: in vitro studies. , 1975, Federation proceedings.